Sirtratumab vedotin

Synonyms: ASG-15ME

Sirtratumab Vedotin (ASG-15ME), is an antibody-drug conjugate (ADC) composed of SLTRK6 (SLIT and NTRK like family member 6, "SLIT and NTRK-like family, member 6") and cytotoxic agent monomethyl auristatin E (MMAE). It delivers a small molecule microtubule-disrupting agent, monomethyl auristatin E (MMAE), to tumor cells expressing SLITRK6. SIRTRATUMAB VEDOTIN has the potential for Bladder Cancer, Metastatic urothelial cancer research.

Sirtratumab vedotin

CAS No. 1824663-83-3

Click to purchase the isotype control of Sirtratumab vedotin

Purity & Quality Control

≥99

Choose Selective Antibody-Drug Conjugate Inhibitors

Biological Activity

Description Sirtratumab Vedotin (ASG-15ME), is an antibody-drug conjugate (ADC) composed of SLTRK6 (SLIT and NTRK like family member 6, "SLIT and NTRK-like family, member 6") and cytotoxic agent monomethyl auristatin E (MMAE). It delivers a small molecule microtubule-disrupting agent, monomethyl auristatin E (MMAE), to tumor cells expressing SLITRK6. SIRTRATUMAB VEDOTIN has the potential for Bladder Cancer, Metastatic urothelial cancer research.

Product Details

CAS No. 1824663-83-3
ADC antiody Sirtratumab
ADC cytotoxin MMAE
Formulation 1xPBS
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Sirtratumab vedotin | Sirtratumab vedotin supplier | purchase Sirtratumab vedotin | Sirtratumab vedotin cost | Sirtratumab vedotin manufacturer | order Sirtratumab vedotin | Sirtratumab vedotin distributor